-
AIM2-driven inflammasome activation in heart failureZ Onódi, M Ruppert, D Kucsera et al. -
Glucose-lowering Drugs or Strategies, Atherosclerotic Cardiovascular Events, and Heart Failure in People With or at Risk of Type 2 Diabetes: An Updated Systematic Review and Meta-Analysis of Randomised Cardiovascular Outcome TrialsOR Ghosh-Swaby, SG Goodman, LA Leite et al.
-
Left Ventricular Assist Devices: Synergistic Model Between Technology and MedicineJJ Han, MA Acker, P Atluri et al.
-
Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart FailureSP Marso, FMM Baeres, and on behalf of the LEADER Trial Investigators.
-
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetesWT Abraham, JA Lindenfeld, P Ponikowski et al.
-
Is Acute heart failure a distinctive disorder? An analysis from BIOSTAT-CHFBA Davison, S Senger, IE Sama et al.
-
SGLT2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction: A Meta-Analysis of the EMPEROR-Reduced and DAPA-HF TrialsF Zannad, JP Ferreira, SJ Pocock et al.
-
Association of loop diuretics use and dose with outcomes in outpatients with heart failure: a systematic review and meta-analysis of observational studies involving 96,959 patientsCJ Kapelios, Μ Bonou, K Malliaras et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
